American Diabetes Association

Table 2—

Glycemic control by study group

Variable	CGMS	Control	P
A1C (%)
Baseline	8.2 (7.8–8.8)	7.9 (7.3–8.3)	0.47
6 weeks	8.0 (7.4–8.5)	7.7 (7.3–8.1)	0.37
12 weeks	7.9 (7.4–8.3)	7.6 (7.2–7.8)	0.21
6 months	8.2 (7.5–8.9)	7.8 (7.3–8.2)	0.25
Change (from baseline to 6 weeks)	−0.2 (−0.5 to −0.1)	−0.2 (−0.5 to 0.2)	0.71
Change (from baseline to 12 weeks)	−0.4 (−0.7 to −0.1)	−0.4 (−0.8 to 0.2)	0.83
Change (from baseline to 6 months)	−0.1 (−0.4 to 0.6)	−0.1 (−0.4 to 0.7)	0.87
Fructosamine (μmol/l)
Baseline	397.5 (367.6–427.4)	400.4 (368.5–430.1)	0.88
6 weeks	384.5 (350.7–411.8)	383.5 (363.8–403.5)	0.95
12 weeks	385.7 (353.1–413.9)	369.2 (344.5–389.7)	0.35
Change (from baseline to 6 weeks)	−16.3 (−43.5 to 10.9)	−16.8 (−47.0 to 15.6)	0.98
Change (from baseline to 12 weeks)	−25.8 (−50.7 to −1)	−18.6 (−60 to 23)	0.59
Final A1C ≤7.5%	10 (53)	8 (47)	0.5
Increase in insulin dose (units · kg⁻¹ · day⁻¹)	0.01	0.03	0.69

Variable	CGMS	Control	P
A1C (%)
Baseline	8.2 (7.8–8.8)	7.9 (7.3–8.3)	0.47
6 weeks	8.0 (7.4–8.5)	7.7 (7.3–8.1)	0.37
12 weeks	7.9 (7.4–8.3)	7.6 (7.2–7.8)	0.21
6 months	8.2 (7.5–8.9)	7.8 (7.3–8.2)	0.25
Change (from baseline to 6 weeks)	−0.2 (−0.5 to −0.1)	−0.2 (−0.5 to 0.2)	0.71
Change (from baseline to 12 weeks)	−0.4 (−0.7 to −0.1)	−0.4 (−0.8 to 0.2)	0.83
Change (from baseline to 6 months)	−0.1 (−0.4 to 0.6)	−0.1 (−0.4 to 0.7)	0.87
Fructosamine (μmol/l)
Baseline	397.5 (367.6–427.4)	400.4 (368.5–430.1)	0.88
6 weeks	384.5 (350.7–411.8)	383.5 (363.8–403.5)	0.95
12 weeks	385.7 (353.1–413.9)	369.2 (344.5–389.7)	0.35
Change (from baseline to 6 weeks)	−16.3 (−43.5 to 10.9)	−16.8 (−47.0 to 15.6)	0.98
Change (from baseline to 12 weeks)	−25.8 (−50.7 to −1)	−18.6 (−60 to 23)	0.59
Final A1C ≤7.5%	10 (53)	8 (47)	0.5
Increase in insulin dose (units · kg⁻¹ · day⁻¹)	0.01	0.03	0.69

Data are means (95% CI).